# Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus

> **NCT06533033** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hams Hamed Abdelrahman** · enrollment: 50 (estimated)

## Conditions studied

- Oral Lichen Planus

## Interventions

- **DRUG:** Rapid Release Capsules Melatoni
- **DRUG:** Triamcinolone Acetonide ointment, Kenacort-A orabase

## Key facts

- **NCT ID:** NCT06533033
- **Lead sponsor:** Hams Hamed Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06533033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06533033, "Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06533033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*